BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15277339)

  • 1. Serum homocysteine and endothelial dysfunction in circulatory disorders in women.
    Tsuda K; Nishio I
    Circulation; 2004 Jul; 110(4):e37. PubMed ID: 15277339
    [No Abstract]   [Full Text] [Related]  

  • 2. Homocysteine, vitamin B6, and endothelial dysfunction in circulatory disorders.
    Tsuda K; Nishio I
    Stroke; 2004 Aug; 35(8):1785; author reply 1785. PubMed ID: 15192236
    [No Abstract]   [Full Text] [Related]  

  • 3. An alternative view of homocysteine.
    Dudman NP
    Lancet; 1999 Dec; 354(9195):2072-4. PubMed ID: 10636386
    [No Abstract]   [Full Text] [Related]  

  • 4. Endothelial function markers in parkinsonian patients with hyperhomocysteinemia.
    Bostantjopoulou S; Katsarou Z; Frangia T; Hatzizisi O; Papazisis K; Kyriazis G; Kiosseoglou G; Kazis A
    J Clin Neurosci; 2005 Aug; 12(6):669-72. PubMed ID: 16040247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium.
    Stanger O; Weger M
    Clin Chem Lab Med; 2003 Nov; 41(11):1444-54. PubMed ID: 14656024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia.
    He L; Zeng H; Li F; Feng J; Liu S; Liu J; Yu J; Mao J; Hong T; Chen AF; Wang X; Wang G
    Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E1061-5. PubMed ID: 20858749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of the atherogenic effects of elevated homocysteine in experimental models.
    Wilson KM; Lentz SR
    Semin Vasc Med; 2005 May; 5(2):163-71. PubMed ID: 16047268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine-Induced Endothelial Dysfunction.
    Lai WK; Kan MY
    Ann Nutr Metab; 2015; 67(1):1-12. PubMed ID: 26201664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of hyperhomocysteinemia on the cellular redox state--impact on homocysteine-induced endothelial dysfunction.
    Weiss N; Heydrick SJ; Postea O; Keller C; Keaney JF; Loscalzo J
    Clin Chem Lab Med; 2003 Nov; 41(11):1455-61. PubMed ID: 14656025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine is an independent risk factor for myocardial infarction, in particular fatal myocardial infarction in middle-aged women.
    Schroecksnadel K; Frick B; Fuchs D
    Circulation; 2004 Jul; 110(4):e37-8; author reply e37-8. PubMed ID: 15277338
    [No Abstract]   [Full Text] [Related]  

  • 11. [Homocysteine and coronary artery disease].
    Aro A
    Duodecim; 2003; 119(12):1131-5. PubMed ID: 12868359
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of tetrahydrobiopterin (BH4) in hyperhomocysteinemia-induced endothelial dysfuction: new indication for this orphan-drug?
    Kietadisorn R; Kietselaer BL; Schmidt HH; Moens AL
    Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1176; author reply E1177-8. PubMed ID: 21427414
    [No Abstract]   [Full Text] [Related]  

  • 13. Homocysteine level in Iranian patients with premature acute myocardial infarction.
    Shojaie M; Naghshvar F; Izadi HR; Eshraghian A; Pourahmad M
    Chin Med J (Engl); 2009 Aug; 122(16):1952-4. PubMed ID: 19787866
    [No Abstract]   [Full Text] [Related]  

  • 14. Asymmetric dimethylarginine (ADMA) and hyperhomocysteinemia in patients with acute myocardial infarction.
    Korandji C; Zeller M; Guilland JC; Vergely C; Sicard P; Duvillard L; Gambert P; Moreau D; Cottin Y; Rochette L
    Clin Biochem; 2007 Jan; 40(1-2):66-72. PubMed ID: 17020756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine and coronary microcirculation: is it a microvasculopathic agent?
    Turhan H; Aksoy Y; Yetkin E
    Int J Cardiol; 2006 Jun; 110(2):269-70. PubMed ID: 16325281
    [No Abstract]   [Full Text] [Related]  

  • 16. Association between endothelial nitric oxide gene intron 4a4b VNTR polymorphism and plasma homocysteine concentrations in Tunisian male patients with myocardial infarction.
    Jemaa R; Kallel A; Sediri Y; Abdessalem S; Mourali MS; Feki M; Mechmeche R; Kaabachi N
    Nutr Res; 2012 May; 32(5):342-6. PubMed ID: 22652373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of allicin on hyperhomocysteinemia-induced experimental vascular endothelial dysfunction.
    Liu DS; Gao W; Liang ES; Wang SL; Lin WW; Zhang WD; Jia Q; Guo RC; Zhang JD
    Eur J Pharmacol; 2013 Aug; 714(1-3):163-9. PubMed ID: 23792140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction.
    van Guldener C; Stehouwer CD
    Semin Thromb Hemost; 2000; 26(3):281-9. PubMed ID: 11011845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of homocysteine-induced atherothrombosis.
    Lentz SR
    J Thromb Haemost; 2005 Aug; 3(8):1646-54. PubMed ID: 16102030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine to hydrogen sulfide or hypertension.
    Sen U; Mishra PK; Tyagi N; Tyagi SC
    Cell Biochem Biophys; 2010 Jul; 57(2-3):49-58. PubMed ID: 20387006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.